- $266.60m
- $221.94m
- €0.03m
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:25 AM
Brief: Inflarx Announces New Pipeline Program – Oral C5AR Inhibitor
Brief: Inflarx Reports Qtrly Loss Per Share Eur 0.38
Brief: Inflarx Announces Decision To Enter Phase 3 Development Of Ifx-1 In Severe Covid-19 Induced Pneumonia
NASDAQ RESUMED AT 10:33 AM
NASDAQ RESUMED AT 10:28 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:21 AM
U.S. STOCKS ON THE MOVE-Tesla, Tonix Pharmaceuticals, Toll Brothers, SmileDirectClub, Ocwen Financial
ChemoCentryx: Set for record high on 'transformational' data, lifts rival Inflarx
U.S. STOCKS ON THE MOVE-PG&E Corp, Teva Pharmaceutical, Humana, Ralph Lauren
U.S. STOCKS ON THE MOVE-Qualcomm, Roku, Ralph Lauren, Hecla Mining, ObsEva
U.S. STOCKS ON THE MOVE-Qualcomm, Fossil, Hecla Mining, Bionano Genomics
InflaRx NV: Leaps on new data on treatment for skin condition
NASDAQ RESUMED
NASDAQ TRADE HALT HALT NEWS PENDING
Brief: Inflarx Reports Cash And Cash Equivalents Plus Securities And Other Investments Of EUR 138.3 Million As Of June 30
U.S. STOCKS ON THE MOVE-Halliburton, Peak Resorts, Taronis Technologies
U.S. STOCKS ON THE MOVE-Peak Resorts, Amneal Pharma, Taronis Technologies
U.S. STOCKS ON THE MOVE-Biohaven, Galapagos, Paysign